InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（1 笔）
内部人交易记录
首席财务官已披露买入
1
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Piekos Brian, 首席财务官. Director active across 3 companies, notably Gemini Therapeutics, Inc. /DE. In total, 6 reports have been published. Split: 1 buy · 1 sell. Total volume traded: €92k. Activity tracked since 14 May 2021. The latest transaction was disclosed on 17 April 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Piekos Brian
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
6,250 股Common StockSEC:0001815308-26-000003:0
1,862 股@ US$20.21630.0025% mcap100.0% 占其流量Common StockSEC:0001815308-26-000003:1
5,000 股Common StockSEC:0001815308-26-000002:0
15,000 股Common StockSEC:0001815308-25-000004:0
9,960 股@ US$1.097.8% 占其流量Common StockSEC:0001209191-22-033719:0
7,655 股@ US$9.46285.6% 占其流量Common StockSEC:0000899243-21-019763:0
标准退出：2021年8月12日 (T+90)
6 条申报中的 6 条
About Piekos Brian
Brian Piekos is the Chief Financial Officer at Gemini Therapeutics, Inc. /DE. He is responsible for the financial management of the company, including financial planning and analysis. His expertise is crucial for ensuring the financial health and compliance of the organization.
